glp-1 news today cardiovascular outcomes 2025 november The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management | Current Risk Reports GLP-1 Agonists in Cardiovascular Diseases:

Taurine conjugates bile acids, helping create bile salts that support fat digestion, bile secretion and the movement of cholesterol and selected compounds into the intestine

Long-term sobriety requires addressing the mental, emotional, and behavioral patterns behind your alcohol use

Counterarguments The link between diet, gut health, and chronic diseases is complex, and while there is evidence supporting these connections, it is not definitive that these factors are the primary cause of all chronic diseases

Efficacy and safety of a new triple-combination agent for the treatment of facial melasma

Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease

What we do not have is a dedicated primary prevention trial showing that treating healthy adults to apoB below, for example 0.6 g/L produces better health outcomes than current practice